Diagnostics

#Diagnostics #Genetics / genomics #Multiomics #Personalised medicine

The power of multiomic integration in diagnostics and drug discovery

DDW’s Megan Thomas speaks with Dr Madhuri Hegde, Senior Vice President and Chief Scientific Officer at Revvity Omics, about how the integration of multiomics is advancing companion diagnostics and personalised medicine. MT: How is the integration of multiomics transforming the landscape of companion diagnostics? MH: We see multiomics as a… Read More

#Exclusive Content

Neurons in the brain
#Alta Neuroscience #Alzheimer's #Biomarkers #Blood-based biomarkers #Diagnostics #Roche

How Roche is advancing Alzheimer’s research

DDW’s Megan Thomas speaks with Dr Maria-Magdalena Patru, Scientific Partner at Roche Diagnostics US, about how advances in Alzheimer’s disease (AD), particularly blood-based biomarkers (BBM), can enable earlier, more accurate, and accessible detection of the disease, supporting timely treatment and improved patient outcomes.  MT: Why is improving AD diagnostics crucial… Read More

#Exclusive Content

#2025 predictions #Diagnostics #Drug discovery

Diagnostics: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience, cancer research and cell and gene therapy. Here, looking through a diagnostics lens.  Jackie… Read More

#Business & Investment #Exclusive Content #Trends & Analysis

#Antibodies #Cancer #Cancer research #Diagnostics #Drug discovery #Fibroblasts #Flow Cytometry #Immunology #Oncology #Tumour biology

Podcast: Flow cytometry for drug discovery research

This is the latest episode of the free DDW narrated podcast, titled “Flow cytometry for drug discovery research” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Flow cytometry technologies and cancer associated fibroblasts and Leveraging… Read More

#News

#Cancer #Diagnostics #Drug discovery #Oncology #Precision medicine

Can liquid biopsies transform precision medicine?

Brett Swansiger, Chief Commercial Officer at ANGLE, discusses the importance of liquid biopsies in precision medicine trials for cancer.   Challenges in the oncology clinical trials space The oncology market is a key growth driver for the pharma industry, with global drug revenues expected to reach US$390 billion by… Read More

#Cancer Research #Exclusive Content

Scientific technology
#AI / data analytics / healthtech / informatics #Clinical development #Data automation #Data management #Diagnostics #Drug discovery #Electronic Lab Notebooks (ELN) #FAIR Principles #Genomics #Immunology / Virology & Vaccines #Infectious diseases #Informatics #mRNA #Personalised medicine #Precision medicine #Predictive diagnostics #Public health

New podcast: Revolutionary technology for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Revolutionary technology for drug discovery and development” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: mRNA technology may hold the future for a cytomegalovirus vaccine; … Read More

#News

Blood samples in lab
#Alzheimer's #Biomarkers #Diagnostics #Neurodegenerative disorders #PharmaKure

Novel blood test identifies Alzheimer’s risk with 97% accuracy

A new blood test has been shown to identify biomarkers for Alzheimer’s disease, providing an early warning of cognitive decline. Early results from PharmaKure, a pharmaceutical company spun out from The University of Manchester, UK, shows a novel whole blood test (ALZmetrix) developed by the company… Read More

#News #Trending News

Women gut microbiome
#Diagnostics #Drug development #Gut microbiome #Microbiome

Microscopic innovations in women’s health 

By Katie Gillette, Senior Project Leader, Eliza French, Analyst, Graham Friedman, Analyst, and Olivia Qiu, Associate, DeciBio.  Earlier this year, we explored the microbiome and its role in drug development across various therapeutic areas. This article… Read More

#Exclusive Content

AI brain partnership
#ACROBiosystems #Diagnostics #Electrophysiology #In vivo #Neuroscience #Partnership

Partnership to accelerate neuroscience drug discovery  

ACROBiosystems, through ACRO Certify and under its Aneuro brand, has launched in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips.   Together, the two companies are committed to a collaborative effort to accelerate neurological drug discovery and commercialisation.  Electrophysiology is a critical part… Read More

#News

#Cancer immunotherapy #Cancer research #Cancer Research Month #Diagnostics #Immunotherapy #Oncology #Precision medicine

National Cancer Research Month: Celebrating drug discovery innovation

From antibody-drug conjugates and RNA, to CRISPR and CAR-T therapy, DDW asked the drug discovery industry what the most important development in oncology over the last five years has been. As the US National Cancer Research Month draws to a close, we asked experts from across… Read More

#Cancer Research #Exclusive Content

#ABL Diagnostics #Collaboration #Cytomegalovirus #Diagnostics #HIV #Human Papillomavirus #Infectious diseases #Laboratory #Microbiology #Roche #Tuberculosis #Viral hepatitis

Roche and ABL Diagnostics expand to South African laboratories  

Roche Diagnostics and ABL Diagnostics have launched a distribution partnership which will see Roche supplying ABLD products to South African laboratories.   Roche now has exclusive rights to distribute products, including the ABL DeepChek assays to laboratories implementing microbiology applications. These applications include HIV, Tuberculosis, Cytomegalovirus, Viral… Read More

#News

Myeloma
#Cancer research #Clinical trials #Diagnostics #Market reporting #Report

Report: inequalities in access to myeloma clinical trials in Europe 

Myeloma Patients Europe (MPE) has launched an advocacy report on addressing access barriers to myeloma clinical trials in Central and Eastern Europe (CEE).   The report, led by the MPE CEE Workgroup on Access, found huge inequalities for patients, confirming reports from MPE CEE members about a lack… Read More

#Cancer Research #Market Reports #News

#Data #Diagnostics #Genetics / genomics #Healthcare #Public health #Rare disease #Whole genome sequencing

Personalising WGS doubles diagnosis of rare diseases 

A new study led by Medical Research Council-funded researchers from UCL has found that tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases.  Context   In 2018, the UK’s department of health announced an NHS Genomic Medicine… Read More

#News

Flow cytometry
#Antibodies #Diagnostics #Drug discovery #Flow Cytometry

Leveraging flow cytometry in drug discovery 

Listen to this article on the DDW podcast: Dr Miguel A Tam, and Dr Kenta Yamamoto, BioLegend, examine the evolution, trends and best practices for smooth and efficient workflows for flow cytometry.  Flow cytometry is a well-established analytical technique that has been supporting reliable diagnostics and… Read More

#News

Protein molecule
#Biomarkers #Cancer #Diagnostics #Precision medicine #Proteomics

South Korean proteomics company Bertis expands to the US

Bertis, a South Korean proteomics-based precision medicine technology company, has established a US-based wholly-owned entity to expand its global presence. The subsidiary, called Bertis Bioscience, aims to establish a San Diego-based CLIA-certified lab facility in early Q4, 2022. It will offer proteomics-based screening and diagnostic tests, as well as an… Read More

#Cancer Research #News

#Diagnostics #Genomics #Personalised medicine #Precision medicine #Predictive diagnostics

Predictive diagnostics: closing the precision medicine gap

Listen to this article on the DDW podcast: Jarret Glasscock, PhD, CEO of Cofactor Genomics explains how diagnostics are emerging as the key to ensuring the right patients get matched to the right therapy, at the right time.  Precision medicine promises a… Read More

#Exclusive Content